相关实验视频

Updated: May 6, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

在分化甲状腺癌中进行手术内粗甲状腺外延伸 (T3b) 评估的准确性和临床意义

Solji An¹, Joonseon Park¹, Kwangsoon Kim¹

¹Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

|December 30, 2025

概括

在甲状腺癌分期内对粗甲状腺外延伸 (ETE) 的术内评估是主观的. 虽然复发率相似,但准确的T3b分期可能会影响无复发生存率,这需要进一步调查.

科学领域:

在瘤学瘤学.
手术病理学手术病理学
甲状腺癌研究研究

背景情况:

美国癌症联合委员会癌症分期系统将粗甲状腺外延伸 (ETE) 分类为T3b.
外科医生的术内评估是主观的,可能会影响准确的T3b分期.
外科手术内ETE总评估的诊断准确性及其对复发结果的影响需要评估.

研究的目的:

在甲状腺癌中评估手术内粗体ETE评估的准确性.
为了确定T3b分期的错误分类是否会影响患者复发的结果.
为了确定不准确的手术内ETE评估的预测因素.

主要方法:

在2017-2022年间对4987名甲状腺切除术患者的分析.
根据手术内发现和最终病理学之间的一致性,分类为组:确认ETE,高估和低估.
临床特征,复发率和不准确评估的预测因素的比较.

主要成果:

在179名怀疑严重ETE的患者中,21.2%没有肌肉入侵病理.
在确诊的外来瘤 (6.4%),高估 (2.6%) 和低估 (3.0%) 组中,复发率没有显著差异.
年龄,瘤位置和淋巴侵入是不准确的手术内评估的独立预测因素.

结论:

在手术内进行的ETE总评估具有显著的不准确率.
虽然即时复发率相似,但准确的T3b分期可能会影响无复发生存率.
需要进一步的长期随访,以确认精确的手术内T3b鉴定的预后意义.

关键词:

甲状腺外延伸甲状腺外延伸在手术内进行评估.复发性复发性复发性带肌肉带肌肉是一种肌肉.甲状腺癌是甲状腺癌.甲状腺切除术是指甲状腺切除术.

更多相关视频

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

相关概念视频

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...